<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Obstetrics and Gynaecology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D4A46024-8714-452C-899F-D2AA5075EE82"><gtr:id>D4A46024-8714-452C-899F-D2AA5075EE82</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A9032356-5E03-4D00-BF4A-1E00ED5A1469"><gtr:id>A9032356-5E03-4D00-BF4A-1E00ED5A1469</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Charnock-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B848E032-A999-4112-BD11-44F1FA87F07A"><gtr:id>B848E032-A999-4112-BD11-44F1FA87F07A</gtr:id><gtr:firstName>Cristin</gtr:firstName><gtr:otherNames>Gregor</gtr:otherNames><gtr:surname>PRINT</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9623012"><gtr:id>F06208B9-D246-4322-8DCF-9086EE224AC2</gtr:id><gtr:title>Reproductive Angiogenesis in Health and Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9623012</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1998-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1516178</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Bayer collaboration</gtr:description><gtr:id>60E158FA-8B47-45B7-96A0-6524BA371298</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>GZ83mTtPAaW-1</gtr:outcomeId><gtr:partnerContribution>As a result of the expertise demonstrated in our published work we have a joint project with Bayer-Schering Pharmaceuticals.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Pfizer collaboration</gtr:description><gtr:id>47873839-F140-471D-A24B-8CE504081D0D</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>KJihZ81HgsC-1</gtr:outcomeId><gtr:partnerContribution>We already had active collaborations with Pfizer Global Research in Sandwich Kent. This has continued, (several joint papers) and we have applied for funding together. We are also negotiating the terms for a project to be funded by Pfizer and carried out in Cambridge.</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This invention relates to the production of rodent endometriosis models by implanting into wild type recipient rodents menstruating endometrium from donor rodents in which an oncogene, such as K-ras, has been activated. Rodent endometriosis models and methods of production and use of such models in screening for therapeutics are provided.</gtr:description><gtr:grantRef>G9623012</gtr:grantRef><gtr:id>F7C63B94-5B32-4919-89FB-3F4AA8C8A1B4</gtr:id><gtr:impact>We have filed a patent to protect our new murine model of endometriosis. We have discussed in some depth this with 3 pharmaceutical companies and 1 in particular is particularly interested.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>MCt3TftgJ3a</gtr:outcomeId><gtr:patentId>WO2009022119</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>MURINE ENDOMETRIOSIS MODELLED BY K-RAS ACTIVATION OF MENSTRUATING ENDOMETRIUM</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>In the course of our basic research we have developed a new model human menstruation and a model of endometriosis. Both of these are in mice and these have furthered our understanding of endometrial function in health and disease</gtr:description><gtr:id>5DB71793-DB72-47F1-A3C9-2ED711DE4240</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>VU44yZBPPoU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Mouse models of menstruation and endometriosis</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Metris Therapeutics Ltd</gtr:companyName><gtr:description>Metris Therapeutics Ltd. was a University of Cambridge biotechnology spinoff that specializes in the research and development of medicines that treat gynecological or women's health disorders. The company is currently developing medicines to treat endometriosis, menstrual pain, and menopause symptoms. Johnson &amp;amp; Johnson was one of Metris' major backers.</gtr:description><gtr:id>1BC1946F-83EA-4892-B585-E2D73A24BB92</gtr:id><gtr:impact>Metris was dissolved in 2009</gtr:impact><gtr:outcomeId>kF2ut4Yd1YY</gtr:outcomeId></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>384B8F19-A06B-4BE9-BFAF-6A4CCF62C9E5</gtr:id><gtr:title>Endometrial-peritoneal interactions during endometriotic lesion establishment.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf296c6243129fdd5d04f294537b2282"><gtr:id>cf296c6243129fdd5d04f294537b2282</gtr:id><gtr:otherNames>Hull ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>3C3626A5129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAD5384C-089B-4332-A23F-F44D88DE6889</gtr:id><gtr:title>Vascular development in embryoid bodies: quantification of transgenic intervention and antiangiogenic treatment.</gtr:title><gtr:parentPublicationTitle>Angiogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d2c43929db3bd27a0bde11ff4f84bc9"><gtr:id>1d2c43929db3bd27a0bde11ff4f84bc9</gtr:id><gtr:otherNames>Evans AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-6970</gtr:issn><gtr:outcomeId>cneJucVAjQz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31963B96-28E0-4966-8984-F3E5E57B76E8</gtr:id><gtr:title>Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta).</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fa5227b38adde6f6277f8b230530ae6"><gtr:id>3fa5227b38adde6f6277f8b230530ae6</gtr:id><gtr:otherNames>Sengupta J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>N4N5W7Q6Njc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BC85E79-C169-4F3B-805C-0B2C5E4272D8</gtr:id><gtr:title>Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>SAvYAMWuxAZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D9FA827-5FC6-4370-BF97-3DF53C41E24C</gtr:id><gtr:title>Transcript profile and localization of Wnt signaling-related molecules in human endometrium.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6121f37b0cfe15ad83c277a792f84d52"><gtr:id>6121f37b0cfe15ad83c277a792f84d52</gtr:id><gtr:otherNames>Cheng CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>D4mu33xHxhq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B97CE5A8-65DF-43A3-AF05-C2BCE312A775</gtr:id><gtr:title>Wnt5a-mediated non-canonical Wnt signalling regulates human endothelial cell proliferation and migration.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6121f37b0cfe15ad83c277a792f84d52"><gtr:id>6121f37b0cfe15ad83c277a792f84d52</gtr:id><gtr:otherNames>Cheng CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>HfvjGUmEoPT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0A14577-7FF6-4155-AA81-508B64FE95BF</gtr:id><gtr:title>Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee7a300117df7cff80b0ee7db93602ca"><gtr:id>ee7a300117df7cff80b0ee7db93602ca</gtr:id><gtr:otherNames>Catalano RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>TjP9o4QJkK4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9D767BD-561E-474D-BDC4-13E2D354157B</gtr:id><gtr:title>Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6121f37b0cfe15ad83c277a792f84d52"><gtr:id>6121f37b0cfe15ad83c277a792f84d52</gtr:id><gtr:otherNames>Cheng CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>sk341Fy96H8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A41D9B1-544E-4E60-BE2C-F5EE87AEFA24</gtr:id><gtr:title>Making the UK's National Health Service cost effective.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21e4d38e3ae5514c8235936767f6895f"><gtr:id>21e4d38e3ae5514c8235936767f6895f</gtr:id><gtr:otherNames>Smith SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>dnF2gZisxaE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE4BDA79-8620-4D56-9E5D-E4832B39F225</gtr:id><gtr:title>Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-alpha in menstrual endometrium and effluent in women with menorrhagia.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff310746e9ace20777a8783a2e3393dd"><gtr:id>ff310746e9ace20777a8783a2e3393dd</gtr:id><gtr:otherNames>Malik S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>mCL8QoYuGiB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>384178CA-F8C6-4403-ACB4-D9D65657601B</gtr:id><gtr:title>VEGF-A loss in the haematopoietic and endothelial lineages exacerbates age-induced renal changes.</gtr:title><gtr:parentPublicationTitle>Microvascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0434b5bd3a793429ddd3e703ce15462c"><gtr:id>0434b5bd3a793429ddd3e703ce15462c</gtr:id><gtr:otherNames>Yamaji M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0026-2862</gtr:issn><gtr:outcomeId>EW4sMLUU8eQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CF5416F-A98D-44E2-9358-07AAEEF354D4</gtr:id><gtr:title>Quantitative cellular and molecular analysis of the effect of progesterone withdrawal in a murine model of decidualization.</gtr:title><gtr:parentPublicationTitle>Biology of reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6121f37b0cfe15ad83c277a792f84d52"><gtr:id>6121f37b0cfe15ad83c277a792f84d52</gtr:id><gtr:otherNames>Cheng CW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-3363</gtr:issn><gtr:outcomeId>tRmeX94Q1qh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B9A2EEA-ED85-423C-B826-A4D626A0281B</gtr:id><gtr:title>Progestin regulates chemokine (C-X-C motif) ligand 14 transcript level in human endometrium.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56f4982e196c09b1425b3781b31a6902"><gtr:id>56f4982e196c09b1425b3781b31a6902</gtr:id><gtr:otherNames>Mokhtar NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>N5CNUYKvA5v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6541E2E0-A63F-4981-AD72-D173848E0849</gtr:id><gtr:title>In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer.</gtr:title><gtr:parentPublicationTitle>Molecular cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/713a4e39b840302747d7a2c8ab3e35bd"><gtr:id>713a4e39b840302747d7a2c8ab3e35bd</gtr:id><gtr:otherNames>Saidi SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1476-4598</gtr:issn><gtr:outcomeId>EuXkwryj5A3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9623012</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>